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Provider Adherence to JNC 7 Guidelines and 
Blood Pressure Outcomes in African Americans 
Rosalind M. Peters, PhD, RN, Ramona Benkert, PhD, APRN-BC, Karyn Butler, MS, CNM, and Nicole Brunelle, MSN 
 
Abstract 
• Objective: To measure provider adherence with the 
Seventh Report of the Joint National Committee on 
Prevention, Detection, Evaluation, and Treatment of 
High Blood Pressure (JNC 7) and assess whether ad- 
herence is associated with improved blood pressure 
(BP) control among low-income African-American 
patients. 
• Design:  Chart review. 
• Setting and participants:  A primary care clinic for 
low-income patients within an urban, university health 
center. Data were obtained from charts of 128 hyper- 
tensive African-American patients enrolled in a larger 
study. 
• Measures: The Hypertension Quality Chart Review 
Index was used to measure adherence in the areas 
of cardiovascular risk assessment, lifestyle modifica- 
tion, pharmacologic treatment, and follow-up care. 
Patient BP was also recorded. 
• Results: Overall provider adherence averaged 76%. 
Mean adherence scores were 85% for cardiovascu- 
lar risk assessment, 57% for lifestyle intervention, 
69% for pharmacologic treatment, and 80% for 
follow-up care. Adherence to follow-up care was 
significantly related to BP goal attainment (r = 0.23; 
p < 0.05). Mean BP values decreased but the 
changes were not significant. Nurse practitioners 
had higher total quality scores, while physicians 
achieved greater decreases in diastolic BP. There 
were no significant differences in BP goal attain- 
ment by provider type. 
• Conclusion: Fairly high adherence with JNC 7 guide- 
lines was noted, but it was not related to BP goal 
attainment. Lower adherence scores may reflect 
problems with documentation rather than practice. 
pressure controlled to less than 140/90 mm Hg, and barely 
half of patients actively treated for HTN have achieved 
recommended blood pressure goals [4]. Blood pressure out- 
comes are worse for African Americans, who have the high- 
est prevalence of HTN and yet have lower rates of control, 
even with treatment, than non-Hispanic whites [4]. 
While these disparities are often attributed to patient fac- 
tors such as increased prevalence of obesity and sedentary 
lifestyles, it is important that provider factors also be exam- 
ined [5]. The Joint National Committee on Prevention, De- 
tection, Evaluation and Treatment of High Blood Pressure 
(JNC) has a 30-year history of providing an evidence-based 
approach to the prevention and management of hyperten- 
sion; however, there is scant literature describing provider 
adherence to JNC guidelines. A recent study [6] found that 
as many as 41% of physicians surveyed remained unaware 
or unfamiliar with JNC recommendations. Other studies 
have found variation in adherence, with rates ranging from 
26% to 72% [7,8]. Most of the previous studies on adherence 
to guidelines have focused on pharmacologic treatment of 
HTN and failed to describe comorbidities or evaluate the 
multiple aspects of care as outlined in the JNC reports [7,9]. 
Only one study was found that evaluated all components of 
the JNC 6 guidelines [10], and none were found that exam- 
ined the latest JNC 7 recommendations. 
Few studies have evaluated adherence to JNC guidelines 
by primary care providers other than physicians. Three 
studies have assessed nurse practitioner care. They found 
that nurse practitioners were able to achieve blood pres- 
sure control rates greater than the 50th percentile based on 
HEDIS measures [11]; achieve significantly lower diastolic 
blood pressure than physicians [12]; and achieve similar 
outcomes in uninsured as insured patients [13]. The cur- 
rent review of the literature reveals that while hypertension 
guidelines are well established, there is little research on 
provider adherence to these national  recommendations; HHTN and lowering blood pressure are well estab-    
ypertension affects the lives of more than 50 million 
American adults [1,2]. The benefits of controlling 
 
lished and include decreases in cardiovascular disease, car- 
diovascular morbidity and mortality, and all-cause mortality 
[3]. Yet only 31% of hypertensive individuals have their blood 
limited research on care by nonphysician providers; scant 
information on the relationship of adherence to guidelines 
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and hypertension outcomes among African Americans; and 
no studies could be found that evaluated the most current 
JNC 7 guidelines. 
The purpose of this study was to determine if provider 
adherence to JNC 7 guidelines improved blood pressure 
control among a group of low-income African-American pa- 
tients with hypertension. Specific aims were (1) to describe 
the levels of adherence to JNC 7 guidelines, (2) to determine 
the relationship between level of adherence and blood pres- 
sure goal attainment, and (3) to compare the level of adher- 
ence and outcome criteria by provider type. 
Methods 
Patient Sample 
The sample consisted of a subset of patients who had been 
recruited to participate in a larger study examining the effect 
of organizational, interpersonal, and technical process vari- 
ables on hypertension outcomes among African Americans 
[14]. Inclusion in the larger study required participants to be 
self-identified as African American, between 18 and 80 years 
of age with a documented diagnosis of hypertension (ICD-9 
codes 401, 401.1, or 401.9), and a patient in the clinic for less than 
18 months. A total of 145 participants were conveniently 
recruited from 2 primary care clinics located in a large urban 
university health center. This paper focuses on the 128 partici- 
pants who received care in the joint-managed clinic. The joint- 
managed clinic serves indigent persons between 21 and 
64 years of age who are eligible to participate in a county- 
funded capitated health insurance program. Strict income lim- 
its ($500/month) are required for participation in the program, 
which includes prescription drug coverage. Care in the joint- 
managedclinicisprovidedbyeithernursepractitionersorphy- 
sicians who are third-year internal medicine residents doing 
their primary care continuity rotation. The University Hu- 
man Investigation Committee granted approval for the study. 
Hypertension Quality Chart Review Index 
To measure provider adherence with JNC 7 guidelines, we 
(RMP and RB) developed the Hypertension Quality Chart 
Review Index (HQI) (Figure). The index contains 4 sub- 
scales that correspond with the main areas addressed in the 
guideline: cardiovascular risk assessment, lifestyle modifica- 
tion, pharmacologic treatment, and follow-up care [3]. The 
instrument yields an overall score and 4 subscores reflecting 
adherence with the recommendations. A point is assigned 
if there is documentation that the guideline recommenda- 
tion was followed. The Figure includes a description of how 
scores are calculated. 
Cardiovascular risk assessment includes evaluation for 
obesity, diabetes, hyperlipidemia, and kidney function. The 
recording of laboratory values for these conditions was ac- 
cepted as if done in the past year. 
Lifestyle interventions were considered addressed if 
teaching related to diet, physical activity, smoking cessation 
(if smoker), alcohol reduction (if history of alcohol abuse or 
reported alcohol consumption beyond recommended limits), 
or stress management was documented at least once in the 
patient record. The JNC 7 guidelines specify the importance 
of teaching diets that emphasize low salt and high fruit and 
vegetable intake as well as encourage weight reduction diets 
if body mass index is 30 Kg/m2 or greater [3]. Given the 
low documentation of any teaching, the diet category was 
collapsed to allow credit for any mention of diet teaching in 
general without specifying the exact diet taught. 
The pharmacologic treatment subscale assessed for use 
of diuretics for patients in general, specific medications 
based on documented comorbidities (eg, angiotensin- 
converting enzyme [ACE] inhibitors for diabetes), and med- 
ication adjustment if patients were not at goal blood pres- 
sure. Goal was based on JNC 7 recommendations related to 
the presence of comorbidities: less than 140/90 mm Hg for 
patients in general, and less than 130/80 mm Hg for patients 
with documented diabetes or kidney disease [3]. 
Follow-up care measures included assessing visit sched- 
ule based on blood pressure levels as well as obtaining 
follow-up creatinine and potassium levels. Visit schedules 
were determined as meeting JNC guidelines if patients who 
were not at goal were seen at least once per month, more 
frequently if stage 2 hypertension, and patients who were at 
goal were seen at least once within 6 months. 
The HQI was intended to be used to assess care provided 
to patients with a known diagnosis of essential hyperten- 
sion. Thus, calcium levels, which are indicative of a second- 
ary cause of hypertension, were not evaluated. Hematocrit 
also was not assessed as all patients had a complete blood 
count done and it was impossible to determine if the hema- 
tocrit was used to evaluate kidney function or as a simple 
screening test for other causes of anemia. Prior to imple- 
mentation, the HQI was reviewed by certified hypertension 
specialists to ensure the content was consistent with JNC 7 
guidelines. 
Data Abstraction and Analysis 
Chart audits were done by master’s and doctorally prepared 
nurses who received over 10 hours of training on data 
collection procedures. Chart review was conducted for a 
6-month period beginning with the first clinic visit at which 
the patient agreed to participate in the study. A 6-month 
time frame was chosen because even hypertensive patients 
whose blood pressure is well-controlled should be seen by 
their provider at least twice per year. In addition to com- 
pleting the HQI, nurses recorded dates of visits, provider 
information, and patient demographic data. The reviewers 
made no judgments regarding probable clinical decisions; 
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IndIcator Present not Present n/a optional comments 
cVd risk assessment 
Height & weight or BMI recorded 1 0 
Waist circumference recorded — — 1 
Cholesterol panel with LDL 1 0 
ECG baseline 1 0 
Urinalysis if nondiabetic 1 0 X 
Urinary albumin excretion or microalbuminuria within 1 0 X 
last year if diabetic or CKD 
Urinary albumin/creatinine ratio — — 1 
HbA1c if diabetic 1 0 X 
Blood glucose if nondiabetic 1 0 X 
total cVd percentage = (present) + (optional)/7 minus n/a      
Lifestyle modification taught 
Physical activity 1 0 
Diet 1 0 
Low salt 
High fruits/vegetables 
Weight reduction if BMI > 30 Kg/m2 
Smoking cessation 1 0 X 
Alcohol reduction 1 0 X 
Stress management — — — 1 
total lifestyle percentage = (present) + (optional)/4 minus   n/a      
Pharmacologic treatment 
Diuretic prescribed 1 0 
ACEI or ARB if diabetic or CKD 1 0 X 
b Blocker post-MI 1 0 X 
Two different classes of medications if stage 2 1 0 X 
Medications adjusted if not at goal 1 0 X 
total pharmacologic percentage = (present)/5 minus n/a      
Follow-up 
At least monthly visits unless at goal (if at goal, 1 0 
2–3 visits/year 
Creatinine 1–2x/year 1 0 
Potassium 1–2x/year 1 0 
total follow-up percentage = (present)/3 minus n/a      
 
total points — — 
overal adherence percentage = (total present) + (optional)/19 minus   n/a      
 
Figure. Hypertension quality chart review index. ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin II recep- 
tor blocker; BMI = body mass index; CKD = chronic kidney disease; CVD = cardiovascular disease; ECG = electrocardiogram; 
HbA1c = glycosylated hemoglobin; LDL = low-density lipoprotein; MI = myocardial infarction. 
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table 1. Baseline Characteristics of  Sample 
 
 audit Sample (Patients  with nonreturning Patients 
≥ 2 Visits) (n = 94) (n = 34) 
Sex, n   
Men 47 (50%) 19 (56%) 
Women 47 (50%) 15 (44%) 
Mean age, yr (range) 49 ± 8 (28–64) 49 ± 8 (34–62) 
Mean education, yr (range) 12 ± 2 (6–20) 12 ± 2 (5–8) 
Mean body mass index, 32.96 ± 7.38 (18.44–54.24) 31.10 ± 9.04 (18.12–56.08) 
Kg/m2 (range) 12% Normal weight 26% Normal weight 
 21% Overweight 32% Overweight 
 38% Obesity I 12% Obesity I 
 12% Obesity II 9% Obesity II 
 17% Obesity III 21% Obesity III 
Mean blood pressure, mm Hg   
Systolic (range) 141.61 ± 19.57 (104–219) 137.38 ± 17.91 (106–174) 
Diastolic (range) 83.02 ± 13.56 (52–148) 81.97 ± 13.67 (58–118) 
Provider type, by visit   
Physician 49 (52%) 26 (78%) 
Nurse practitioner 45 (48%) 7 (22%) 
 
 
index criteria were determined to be met or not met based 
solely on information documented. The provider seen most 
consistently by the patient was entered as the usual provider 
for data analysis purposes. 
Relationships among subscales and total scores were 
calculated using Pearson’s product-moment correlation. 
Differences in subscale and total scores and blood pressure 
outcomes were calculated using independent sample t tests 
or chi-square statistics. 
results 
The baseline characteristics of our sample are shown in 
Table 1. Of the original 128 patients, 26% (n = 34) did not 
have a second visit in the 6-month study period; thus, any 
changes in blood pressure were not available in the chart. 
An HQI score was calculated for the remaining 94 patients 
who had at least 2 documented visits in 6 months. Results 
for this group of 94 patients are reported. 
There were no significant differences between the pa- 
tients who did and did not return for a second visit based 
on sex, age, or education (Table 1; α = 0.05; 1-b= 0.70). There 
were significant differences noted based on provider; 86% 
of patients initially seen by a nurse practitioner (45 of 52) 
returned for at least 1 follow-up visit compared with 64% of 
patients initially seen by a physician (49 of 76 [X2 = 6.66; P = 
0.01]). Three participants who had an initial physician visit 
received follow-up care with a nurse practitioner. Forty-five 
percent of the patients were able to see the same provider for 
all of their visits (provider consistency of 100%), while the 
other patients saw the same provider for more than half of 
their visits (provider consistency of 58%) 
The 94 patients in the quality analysis had a total of 364 
visits, or an average of 4 visits during the 6-month study 
period. Twenty-four percent of the patients had diabetes, 5% 
had chronic kidney disease, and another 5% had both diabe- 
tes and kidney disease. There were no provider differences 
related to patient comorbidities. 
Cardiovascular Risk Assessment 
The degree of adherence with recommended cardiovascular 
risk assessment ranged from 20% to 120%. Scores above 
100% reflect documentation that the provider performed “op- 
tional” recommendations (eg, obtaining a urinary albumin/ 
creatinine ratio). The average score in this category was 85%, 
the highest of all subscale scores (Table 2). All patients had 
height and weight recorded, but body mass index was docu- 
mented for only 4 patients. The majority of patients had docu- 
mented baseline electrocardiograms (78%), cholesterol (93%), 
and blood glucose if not diabetic (88%). Among diabetic 
patients, 90% had glycosylated hemoglobin and 69% had mi- 
croalbuminuria examinations done. Urinalysis in nondiabetic 
patients was documented only 43% of the time. There was no 
significant difference in cardiovascular risk assessment scores 
between physicians and nurse practitioners. 
Lifestyle Modification 
The average score for teaching related to lifestyle interven- 
tion was 57%, with scores ranging from 0 to 150% (Table 2). 
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table 2. Adherence to JNC 7 Guidelines and Blood Pressure  Outcomes 
all Physicians nurse Practitioners Significance 
Mean cardiovascular risk assessment 
score (range) 
Mean lifestyle modification score 
(range) 
Mean pharmacologic treatment score 
(range) 
0.85 ± 0.18 (0.20–1.20) 0.85 ± 0.18 0.84 ± 0.17 p = 0.79 
 
0.57 ± 0.49 (0–1.50) 0.44 ± 0.45 0.69 ± 0.50 t(92) = 2.53 
p = 0.01 
0.69 ± 0.33 (0–1.00) 0.75 ± 0.32 0.63 ± 0.33 p = 0.09 
 
Mean follow-up score (range) 
Mean total quality score (range) 
Change in blood pressure, mm Hg 
0.80 ± 0.23 (0–1.00) 
0.76 ± 0.16 (0.27–1.08) 
0.81 ± 0.22 
0.75 ± 0.15 
0.79 ± 0.25 
0.77 ± 0.17 
p = 0.67 
p = 0.45 
Systolic (range) –1.63 ± 19.74 (+44 to –60) –4.76 ± 19.47 +1.37 ± 19.74 p = 0.13 
Diastolic (range) –2.26 ± 13.03 (+26 to –41) –5.96 ± 14.23 +1.28 ± 10.76 t(92) = 2.79 
p = 0.006 
Blood pressure goal achieved*    p = 0.42 
Yes 44% (n = 41) 52% (n = 24) 40% (n = 19)  
No 56% (n = 53) 48% (n = 22) 60% (n = 29)  
NOTE: Providers who documented performing “optional” recommendations could achieve greater than 100% adherence. 
*Less than 130/80 mm Hg if diabetes or chronic kidney disease, less than 140/90 mm Hg all others. 
 
 
The mean number of times teaching was documented in 
any category was once, even though patients had a average 
of 4 visits where teaching could have occurred. Despite the 
high prevalence of obesity in the sample, dietary instruction 
was documented for only 57% of the patients and exercise 
instruction was documented for only 46%. Of the 41 patients 
who were self-identified as smokers, less than half had docu- 
mentation of smoking cessation instruction. Of the 23 patients 
reporting an alcohol problem, 67% received alcohol cessation 
instruction. Nurse practitioners were significantly more likely 
than physicians to document teaching lifestyle interventions. 
Pharmacologic Treatment 
With regard to pharmacologic treatment, providers were 
adherent with JNC 7 guidelines 69% of the time (Table 2). 
All patients were on at least 1 antihypertensive medica- 
tion. Eighty-one percent of the patients were on a diuretic, 
88% of the patients with either diabetes or chronic kidney 
disease were on an ACE inhibitor or angiotensin II receptor 
blocker. The one patient who was post–myocardial infarc- 
tion was not on a b blocker. Ninety-three percent (28 of 
30) of patients with stage 2 hypertension were on at least 
2 antihypertensive medications. The total number of anti- 
hypertensive drugs prescribed ranged from 1 to 5, with 
patients being on an average of 2.20 drugs. For patients not 
at goal, the average was slightly higher at 2.34. There were 
no significant differences between provider type in total 
number of medications prescribed or overall pharmacologic 
treatment scores. Physicians were significantly more likely 
to adjust the medications prescribed if the patient was not at 
 
goal (X2 = 5.04; P = 0.025), but adjusting medications was not 
significantly associated with goal attainment or decrease in 
systolic or diastolic blood pressure. 
Follow-up Care 
Providers were in adherence with follow-up recommenda- 
tions 80% of the time. Within the past year, 90% of the pa- 
tients had creatinine levels checked and 89% had potassium 
levels checked. The visit schedule adherence was 62%. 
Overall Quality and Goal Attainment 
All 4 subscales were positively and significantly related to 
the total quality index score (P < 0.001; Table 3). Although 
providers achieved 76% adherence with the JNC 7 guide- 
lines, the overall quality score was not related to attainment 
of blood pressure goal (< 130/80 mm Hg for patients with 
diabetes or chronic kidney disease or < 140/90 mm Hg for 
all others). At the end of the study period, 44% were at goal. 
When the less stringent criteria of less than 140/90 mm Hg 
was used for all patients, 50% of the sample attained their 
blood pressure goal. Only the follow-up care subscale score 
was significantly related to blood pressure goal attain- 
ment (r = 0.23; P = 0.03). In addition to assessment of goal 
attainment, change in blood pressure also was evaluated. 
Overall, mean blood pressure values decreased during the 
study period, but the changes were not significant for the 
total group. Patients seen by physicians had a significantly 
greater decrease in diastolic pressure than those seen by 
nurse practitioners, achieving almost a 6 mm Hg decrease 
(Table 2). There was no significant relationship between any 
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table 3. Correlation Matrix  
 cVd Lifestyle Pharmacologic   
 assessment Modication treatment Follow-up total Score BP at Goal 
CVD risk assessment —     
Lifestyle modification taught 0.027 —    
Pharmacologic treatment 
Follow-up 
0.242* 
0.374‡ 
0.285† 
–0.159 
— 
0.054 
 
— 
 
Total quality index score 0.667‡ 0.617‡ 0.568‡ 0.439‡ — 
BP at goal 0.180 –0.128 0.011 0.228* 0.087 — 
Mean 0.85 0.57 0.69 0.80 0.76 
SD 0.18 0.49 0.33 0.23 0.16 
BP = blood pressure; CVD = cardiovascular disease; SD = standard deviation. 
*p < 0.05. 
†p < 0.01. 
‡p < 0.001. 
 
subscale or total quality score and change in systolic or dia- 
stolic blood pressure. Nurse practitioners had slightly higher 
quality scores (ie, increased adherence with guidelines), and 
physicians had slightly higher rates of blood pressure goal 
attainment, but neither of these findings were statistically 
significant. 
Because health outcomes may be affected by the patient- 
provider relationship, we evaluated blood pressure outcomes 
controlling for the consistency with which patients saw the 
same provider at each visit. The Brice continuity of care index 
[15] was used to calculate provider consistency scores. Nurse 
practitioners had significantly greater consistency in patient 
visits than physicians (t (92) = 4.85; P < 0.001), but consistency 
was not associated with any of the quality index scales. There 
was an unexpected inverse relationship found in that less 
provider consistency was associated with greater decreases 
in diastolic blood pressure (r = –0.24; P = 0.019). 
discussion 
This study evaluated provider adherence with JNC 7 guide- 
lines using a comprehensive quality index. Providers in 
this urban clinic for low-income patients achieved a level 
of adherence higher than that documented in other studies 
[7,10]. The highest quality score was obtained in the area of 
cardiovascular risk assessment, which suggest that provid- 
ers are cognizant of the risk factors contributing to target 
organ damage. However, evaluating for kidney disease risk 
was not well documented, as less than half of nondiabetic 
patients had urinalysis performed and nearly a third of the 
diabetic patients were not assessed for microalbuminuria 
or proteinuria. Additionally, while the vast majority of 
patients had creatinine levels drawn, it is unclear from the 
chart reviews if providers used that data to calculate the 
estimated glomerular filtration rate, which is not included 
in the laboratory reports. For patients with a diagnosis of 
diabetes or chronic kidney disease, there was wide accep- 
tance of treating with an ACE inhibitor or angiotension II 
receptor blocker. 
Lifestyle modification was the category with the low- 
est quality score and the only guideline area in which 
there were significant provider differences. The deficits in 
documentation of lifestyle teaching warrant comment in 
light of the current trend of “pay for performance” quality 
monitoring [16,17]. The current reimbursement structure 
creates disincentives for teaching and counseling during 
the clinical visit, which contradicts national guidelines and 
quality of care recommendations [17]. Moreover, recent 
analyses suggest that “paying” for performance may not be 
an effective incentive for improved quality [18], especially 
in patients with comorbid conditions [19]. Yet, as the pay for 
performance assessments move from a productivity-based 
incentive plan to a focus on quality, the documentation 
of care according to established guidelines will become a 
critical factor in provider evaluations. Until such time that 
electronic health records are standard within most health 
systems and a balance between productivity and quality 
assessments are the norm, documentation of teaching and 
counseling will continue to be a challenge to the quality 
monitoring process [20]. 
In this group of low-income African-American patients, 
stringent blood pressure goals were met among 44% of the 
patients, and 50% achieved the blood pressure goal of less 
than 140/90 mm Hg, which is comparable with national 
averages [4]. Although providers were 69% adherent with 
pharmacologic treatment guidelines, 62% of the patients who 
were not at goal were taking less than 3 antihypertensive 
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medications. Numerous studies have shown that it takes an 
average of 3.4 medications to achieve blood pressure control 
[3]. Additionally, 64% of patients not at goal at a particular 
visit did not have their medication intensified. 
Follow-up visit schedule was the only factor significantly 
related to blood pressure goal attainment, but there was no 
correlation between visit schedule and medication adjust- 
ment. Follow-up visits without a purposeful link to treat- 
ment intensification may not be a cost-effective strategy for 
hypertension management. Although blood pressure goals 
were not achieved for half of the patients, a decrease of 
5 mm Hg in systolic blood pressure and of 6 mm Hg in 
diastolic blood pressure in the physician group is an im- 
portant finding. Contrary to previous research [21–23], pro- 
vider consistency was inversely related to changes in blood 
pressure, raising the question of whether being unfamiliar 
with the patient or discontinuity resulted in resident physi- 
cians being more aggressive with blood pressure manage- 
ment. A study of nurse practitioners found that longer-term 
relationships diverted the provider and patient toward al- 
ternate social or family issues and away from the “medical” 
aspects of care [24], suggesting that an emphasis on relation- 
ship building could be deleterious to the patient’s physical 
health. Anecdotal findings in the current study, however, 
revealed that nurse practitioner documentation focused on 
multiple medical issues at most visits (eg, vaginitis, mam- 
mograms, Pap smears), whereas physician documentation 
focused on blood pressure management. A larger sample 
and a study that specifically addresses follow-up care, medi- 
cation intensification, prescription usage, and the nuances of 
chronic disease management would provide a better under- 
standing of the relationship among these variables [25]. The 
fact that 26% of the original subjects did not return for a sec- 
ond visit in 6 months and the majority of those patients were 
seen by a resident physician underscores the importance of 
evaluating the interpersonal processes that affect trust and 
patient willingness to return for care [26]. 
This study also evaluated differences in guideline adher- 
ence and hypertension outcomes by provider type. Differenc- 
es were noted in certain aspects of the care provided. Patients 
seen by nurse practioners were significantly more likely to 
return for at least 1 follow-up visit and receive lifestyle teach- 
ing in all areas, while physicians were more likely to make 
medication adjustments and achieved greater reductions in 
diastolic blood pressure readings. The diastolic blood pres- 
sure reduction difference contradicts earlier research compar- 
ing nurse practitioners and physicians [12,27]. However, these 
findings are consistent with other research that has shown 
that nurse practitioners and physicians achieve similar health 
outcomes but use different processes of care [12,27–30]. 
Nurse practitioner education places significant emphasis 
on the interpersonal aspects of care. As a result, nurse prac- 
titioners are more likely to spend time teaching and counsel- 
ing patients regarding lifestyle changes prior to intensifying 
pharmacologic treatments as compared with physicians. In 
contrast, resident physicians report low rates of cardiovas- 
cular disease counseling [31] and low confidence in lifestyle 
counseling interventions in primary care [31,32]. Although 
behaviors can be increased and confidence gained through 
targeted interventions [32–34], resident physicians report 
numerous barriers to behavioral counseling, including time 
limitations, perceived ineffectiveness, and a lack of training 
[35–38]. Given that more than half of the patients seen by 
both types of providers did not attain blood pressure goal 
suggests that a collaborative model of care may be an effec- 
tive option for achieving better control and a higher overall 
level of quality of care. One study compared the quality of 
hypertension outcomes for groups treated by physicians 
versus groups treated by a physician-nurse (non–nurse 
practitioner nurses) team [39]. The physician-nurse team 
demonstrated lower mean systolic and diastolic pressures 
and a higher score for blood pressure medication knowl- 
edge. Unfortunately, the paper did not define the dynamics 
of the nurse-physician team, leaving unclear the effect of the 
nurse’s role or whether members of the team had contact 
with the patient together or individually. Other research has 
found that patients’ lack of understanding of the disease 
process, concerns over side effects of medications, and lack 
of shared decision making are associated with lack of adher- 
ence to antihypertensive regimens [40,41]. A team approach 
that combines the interpersonal emphasis of the nurse prac- 
titioner with the technical emphasis of the physician could 
be a viable solution to these nonadherence challenges. 
Findings from the current study need to be interpreted 
in light of the study limitations. The number of returning 
patients was small and reflects a potential selection bias. 
Additionally, although the patients had severe income limi- 
tations, they had access to both health care and medications. 
It may be that these 2 factors are more important than guide- 
line adherence in achieving blood pressure control. Ad- 
ditionally, the current study shares the limitations common 
to quality audits and chart reviews. Nurse completion of 
the HQI was time- and effort-intensive. The time-intensive 
nature of comprehensive quality indicator tools is a well- 
known dilemma in the area of process improvement [11]. 
Developing standardized instruments and data collection 
processes to ensure the reliability and ease of use of quality 
measures is an important step in improving the quality of 
care provided to patients with hypertension. Additionally, 
chart reviews are limited by the level of documentation 
recorded. Such reviews cannot determine if the deficit 
noted is due to level of provider skill or reflective of time 
and documentation constraints. A comparison of providers 
across a variety of documentation systems would provide 
origiNAl reseArch 
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insight into the usefulness of the HQI to assess the quality 
of care provided. 
quality in nurse-managed centers using HEDIS measures. 
J Healthc Qual 2005;27:4–14. 
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